Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Women's Choice Pharmaceuticals was a specialty pharmaceutical company dedicated to providing high-quality healthcare products specifically for women. The company focused on developing and marketing products in the areas of prenatal care, iron supplementation, and general women's wellness. Its portfolio included branded nutritional supplements and therapeutic products designed to meet the unique physiological needs of women throughout various life stages. In 2014, the company was acquired by Duchesnay USA, a pharmaceutical company specializing in maternal-fetal medicine, to expand its footprint in the women's health market. The acquisition allowed for the integration of WCP's established product lines into Duchesnay's broader obstetric and gynecological portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Womens Choice.